StockData
Medicenna Therapeutics Corp. logo

Medicenna Therapeutics Corp. (MDNAF) stock

MDNAFOTCPharmaceutical PreparationsFiscal year ends March 31
Financials through fiscal 2023, year ended Mar 31, 2023Last filing: 20-F on Jun 27, 2023
$0.28−0.02 (-7.63%)

Close on Oct 19, 2026

Medicenna Therapeutics enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Medicenna Therapeutics's enterprise value was -$4.40M on Oct 19, 2026, against $48.51M a year earlier. Over the last 5 years it ranged from -$11.60M to $119.53M, with a median of $25.28M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Oct 19, 2026-$4.40M-119.5%
2025Dec 31, 2025$22.59M-60.0%
2024Dec 31, 2024$56.40M–
2023Dec 29, 2023-$4.21M-140.8%
2022Dec 30, 2022$10.31M-83.8%
2021Dec 31, 2021$63.51M-68.4%
2020Dec 31, 2020$201.23M+177.7%
2019Dec 31, 2019$72.47M–

More Medicenna Therapeutics figures

See a number that looks wrong?